The company acquired a land plot next to EIPICO 2 plant in 10th of Ramadan City.
The new plant is spanned over an area of 10,345 square meters.
Furthermore, the pharma company agreed with an international engineering consultant to handle the project.
The company’s consolidated net profit reached EGP 487.4 million in 2020.
EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW